September 1 2026 - Simcere Zaiming，a subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced that it has entered into an exclusive global...

July 10, 2026 – Simcere Pharmaceutical Group (2096.HK) today announced that it has entered into a global drug discovery and development collaboration ...

On May 29, 2026, Pacific Time, Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine t...

On June 3, Simcere Zaiming announced that SIM0613 initiated a Phase I clinical trial, with the first patient enrolled in China on June 2, 2026. SIM061...